HONG KONG, May 21 (Reuters) - Former Barclays PLC analyst and healthcare specialist Jason Mann plans to launch hisown hedge fund in June with a focus on the healthcare sector inemerging markets.
Mann, who was a Greater China healthcare equity researchanalyst at the British bank until last year, is setting up FenexCapital Management in Hong Kong, he told Reuters in an e-mail.
The equities long/short fund's initial capital will comefrom Hoyoung Huh, a healthcare entrepreneur and chairman of U.S.based cancer drug developer Stempar Sciences Inc.
Mann, a Harvard alumnus, did not disclose the amount ofstart-up capital.
Acting as fund advisor will be Christophe Lee, the formerchairman of the Hong Kong chapter of the Alternative InvestmentManagement Association, a hedge fund industry body.
Hedge fund activity in Asia is picking up after regionalfunds returned nearly 16 percent to investors last year, theirbest annual performance since 2009, according to data fromEurekahedge.
The industry also added $20 billion in assets in 2013, thefirst growth in three years, according to AsiaHedge. (Reporting by Nishant Kumar; Editing by Christopher Cushing)
Barclays (BARC)